The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to TaxotereJing Li, Dehua Yu|Journal of Translational Medicine|2013Cited by 79
Inhibition of STAT3 Signaling Pathway by Terphenyllin Suppresses Growth and Metastasis of Gastric CancerDehua Yu, Jiang‐Jiang Qin|Frontiers in Pharmacology|2022Cited by 20